Systematic review and meta-analysis of the risk of severe and life-threatening thromboembolism in cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab). (2016)


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 27450994

Publication URI:

Type: Journal Article/Review

Volume: 139

Parent Publication: International journal of cancer

Issue: 10

ISSN: 0020-7136